Tadalafil for benign prostatic hyperplasia: an update.
D002243:Carbolines / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors